Second disappearance an “unfortunate coincidence”
Written by Kate Ross, Chief Marketing Officer

Authorities are investigating the disappearance of a second individual who was who was enrolled in one of Lazar’s clinical trials. George Lazar, President and CEO of Lazar Pharmaceuticals, calls this second disappearance “an unfortunate coincidence” and reiterates that as of this time, “there have been no charges filed and no accusations made regarding any criminal or improper activity on behalf of Lazar Pharmaceuticals.”
Comments are closed.